Business Context and Reporting Period
This Form 8-K Current Report was filed by The Clorox Company (CLX) on January 23, 2025. The filing discloses significant changes in executive leadership, specifically the departure of the Chief Financial Officer and the appointment of a successor.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on personnel changes and associated compensation adjustments.
Material Changes
- Departure of CFO: Kevin Jacobsen, Executive Vice President and Chief Financial Officer, announced his retirement effective April 1, 2025, after nearly 30 years of service. He will serve in an advisory capacity until June 2025.
- Appointment of New CFO: Luc Bellet, currently Vice President – Treasurer, was appointed Executive Vice President and Chief Financial Officer, effective April 1, 2025. Mr. Bellet has been with the company since 2006.
- Compensation Adjustments: Effective April 1, 2025, Mr. Bellet's base salary will increase to $725,000. His short-term incentive target will increase from 50% to 100% of his salary.
- Equity Grants: Mr. Bellet will receive restricted stock units with an aggregate fair value of $400,000 (vesting over four years) and performance shares with an aggregate target fair value of $600,000 (three-year performance period ending June 30, 2027).
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding business performance. No specific risks or contingencies related to financial operations are disclosed in this report, other than the standard transition of executive duties.
Investor Verification Checklist
- Verify the transition timeline for the CFO role between April 1, 2025, and June 2025.
- Review the total compensation package for the new CFO, including the $1.325 million in total target value (salary, incentive, and equity) for the first year.
- Confirm the absence of familial relationships or related party transactions involving the new appointee as stated in the filing.
- Check for any subsequent filings regarding the specific terms of Mr. Jacobsen's advisory role.